1 – 1 of 1
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article